Skip to main content

Right Ventricular Congenital Cardiopathies

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
1 program
Melody valve implantationN/A
Medtronic
MedtronicNJ - Phillipsburg
1 program
Melody valve implantationN/A1 trial
Active Trials
NCT02023775Completed409Est. Oct 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MedtronicMelody valve implantation

Clinical Trials (1)

Total enrollment: 409 patients across 1 trials

NCT02023775MedtronicMelody valve implantation

Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™

Start: Jan 2010Est. completion: Oct 2013409 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.